Hepatoprotective effect of Apocynum venetum L extract on fatty liver disease of 2K1C rats with high-fat and refined-carbohydrate diet

World Chinese Journal of Digestology

Volumn 17, Issue 2, 2009, Pages 135-140

  Yang, Xin Bo ^a   Wu, Xiang Qi ^b   Yang, Jie Ren ^b   Huang, Zheng Ming ^c   Chen, Hong Yan ^a   Cao, Wen Bin ^c   Gen, Miao ^a   Wang, Jian Hua ^a   Wen, Hang Yuan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c Hospital 302 of Chinese PLA   (China)

Author keywords

Apocynum venetum L; Leaf extract; Metabolic syndrome; Nonalcoholic fatty liver disease; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; APOCYNUM VENETUM EXTRACT; ASPARTATE AMINOTRANSFERASE; CAPTOPRIL; CARBOXYMETHYLCELLULOSE; EOSIN; FAT DROPLET; FATTY ACID; GLUTATHIONE PEROXIDASE; HEMATOXYLIN; INSULIN; MALONALDEHYDE; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOCYNUM; ARTICLE; BODY WEIGHT; CARBOHYDRATE DIET; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENZYME BLOOD LEVEL; FATTY LIVER; INSULIN BLOOD LEVEL; LIPID DIET; LIPIDOSIS; LIVER CELL; LIVER PROTECTION; LIVER WEIGHT; LOW DRUG DOSE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; RAT; STAINING; SYSTOLIC BLOOD PRESSURE;

EID: 66249102260     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i2.135     Document Type: Article

References (30)

1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374 (Pubitemid 38702847)
3. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-827
4. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 108-113 (Pubitemid 38183868)
5. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Fagà E, Silli B, Pagano G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003; 37: 909-916 (Pubitemid 36397404)
6. Angulo P, Keach JC, Bat t s KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362
7. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850 (Pubitemid 33641605)
8. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845
9. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001; 15: 1667-1672 (Pubitemid 32912411)
10. Tagawa C, Kagawa T, Nakazawa Y, Onizuka S, Nishibe S, Kawasaki H. [Studies on antihypertensive effect of Luobuma (Apocynum venetum L.) leaf extract (3)] Yakugaku Zasshi 2004; 124: 851-856
11. Kim DW, Yokozawa T, Hattori M, Kadota S, Namba T. Inhibitory effects of an aqueous extract of Apocynum venetum leaves and its constituents on Cu(2+)-induced oxidative modification of low density lipoprotein. Phytother Res 2000; 14: 501-504
12. Xiong Q, Fan W, Tezuka Y, Adnyana IK, Stampoulis P, Hattori M, Namba T, Kadota S. Hepatoprotective effect of Apocynum venetum and its active constituents. Planta Med 2000; 66: 127-133 (Pubitemid 30164353)
13. Prieto-Carrasquero MC, Botros FT, Pagan J, Kobori H, Seth DM, Casarini DE, Navar LG. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 2008; 51: 1590-1596
14. Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y, Nakanuma Y, Kaneko S, Takamura T. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology 2008; 48: 109-118
15. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007; 27: 173-193 (Pubitemid 46871663)
16. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343: 1467-1476
17. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100 (Pubitemid 38056380)
18. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002; 35: 367-372 (Pubitemid 34106376)
19. Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H, Tamagawa Y. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 2007; 31: S61-S66 (Pubitemid 46114917)
20. Jiao K, Liu H, Chen J, Tian D, Hou J, Kaye AD. Roles of plasma interleukin-6 and tumor necrosis factor-alpha and FFA and TG in the development of insulin resistance induced by high-fat diet. Cytokine 2008; 42: 161-169
21. Kagiyama S, Varela A, Phillips MI, Galli SM. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension 2001; 37: 371-375 (Pubitemid 32198995)
22. Yamagishi S, Takenaka K, Inoue H. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation. Med Hypotheses 2006; 66: 118-120 (Pubitemid 41605116)
23. Lapenna D, De Gioia S, Mezzetti A, Ciofani G, Di Ilio C, Cuccurullo F. The prooxidant properties of captopril. Biochem Pharmacol 1995; 50: 27-32
24. Benzie IF, Tomlinson B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br J Clin Pharmacol 1998; 45: 168-169 (Pubitemid 28045686)
25. Ernsberger P, Johnson JL, Rosenthal T, Mirelman D, Koletsky RJ. Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. Am J Hypertens 2007; 20: 866-874 (Pubitemid 47176345)